B. Lactis HN019 for Functional Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Constipation
Interventions
DIETARY_SUPPLEMENT

B. lactis HN019

Capsule containing 10 billion cfu B. lactis HN019 once a day

DIETARY_SUPPLEMENT

B. lactis HN019

Capsule containing 1 billion cfu B. lactis HN019 once a day

DIETARY_SUPPLEMENT

Placebo

Capsule containing no probiotic once a day

Trial Locations (12)

75010

Research Across America, Carrollton

75024

Village Health Partners, Plano

75093

North Texas Family Medicine, Plano

77025

Discovery Clinical Trials South Main, Houston

77054

Research Across America, Dallas

77450

Research Across America, Katy

85306

Arrowhead Family Health Center, Glendale

91325

StayWell Research, Northridge

91361

Westlake Medical Research, Westlake Village

92024

Diagnamics, Inc., Encinitas

92840

Digestive & Liver Disease Specialists, Garden Grove

94109

Sprim ALS, San Francisco

Sponsors
All Listed Sponsors
collaborator

DuPont Nutrition and Health

INDUSTRY

lead

Fonterra Research Centre

INDUSTRY

NCT01463293 - B. Lactis HN019 for Functional Constipation | Biotech Hunter | Biotech Hunter